• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性冠状动脉综合征患者的胆固醇亚组份分析。

Cholesterol Subfraction Analysis in Patients with Acute Coronary Syndrome.

机构信息

Department of Intensive Cardiac Therapy, Central Teaching Hospital of the Medical University of Lodz, Lodz, Poland.

Department of Nephrology, Hypertension and Family Medicine, WAM Teaching Hospital, Zeromskiego 113; 90-549 Lodz, Poland.

出版信息

Curr Vasc Pharmacol. 2019;17(4):365-375. doi: 10.2174/1570161116666180601083225.

DOI:10.2174/1570161116666180601083225
PMID:29852873
Abstract

BACKGROUND

There is a close relationship between lipid metabolism disorders and atherosclerosis. Guidelines focus on lowering Low-Density Lipoprotein Cholesterol (LDL-C) levels. However, it should be kept in mind that LDL and High-Density Lipoprotein (HDL) consist of subfractions which can affect the progression of atherosclerosis.

OBJECTIVE

We assessed the concentration of LDL and HDL subfractions in patients with Acute Coronary Syndromes (ACS). The influence of the presence of type 2 diabetes mellitus on LDL and HDL subfractions was also analyzed.

METHODS

The study group consisted of 127 patients (62 men, 65 women) with ACS. All patients had coronary angiography and coronary angioplasty and stenting when necessary. Medical history was collected during 12 months of follow-up. HDL and LDL subfraction distribution was measured using Lipoprint (Quantimetrix).

RESULTS

No differences in LDL nor HDL subfractions were observed between ST-Segment Elevation Myocardial Infarction (STEMI), Non-ST-Segment Elevation Myocardial Infarction (NSTEMI) and unstable angina (UA) patients. However, those with restenosis and the necessity of repeated revascularization had higher levels of intermediate-density lipoprotein C (IDL-C) (p=0.055) and LDL3 (p=0.048) as compared with the patients without, while the level of IDL A (IDLA) was lower than in the latter group (p=0.036). In diabetic patients, the percentage share of HDL10 and small-dense HDL was significantly higher while the share of HDL1 (small-dense) (p=0.028), HDL4 (intermediate density) (p=0.052) and HDL5 (intermediate density) (p=0.060) were lower than in patients without DM.

CONCLUSION

Patients with multi-vessel CAD disease had higher levels of LDL3 subfraction and IDL-C and a lower proportion of IDLA.

摘要

背景

脂质代谢紊乱与动脉粥样硬化密切相关。指南侧重于降低低密度脂蛋白胆固醇(LDL-C)水平。然而,应该记住,LDL 和高密度脂蛋白(HDL)由亚组分组成,这会影响动脉粥样硬化的进展。

目的

我们评估了急性冠状动脉综合征(ACS)患者的 LDL 和 HDL 亚组分浓度。还分析了 2 型糖尿病对 LDL 和 HDL 亚组分的影响。

方法

研究组包括 127 名 ACS 患者(62 名男性,65 名女性)。所有患者均接受冠状动脉造影和必要时进行冠状动脉血管成形术和支架置入术。在 12 个月的随访期间收集了病史。使用 Lipoprint(Quantimetrix)测量 HDL 和 LDL 亚组分分布。

结果

STEMI、NSTEMI 和不稳定型心绞痛(UA)患者之间的 LDL 和 HDL 亚组分无差异。然而,与无再狭窄和无需再次血运重建的患者相比,有再狭窄和需要重复血运重建的患者中间密度脂蛋白 C(IDL-C)(p=0.055)和 LDL3(p=0.048)水平更高,而 IDL A(IDLA)水平较低(p=0.036)。在糖尿病患者中,HDL10 和小而密 HDL 的百分比明显更高,而 HDL1(小而密)(p=0.028)、HDL4(中间密度)(p=0.052)和 HDL5(中间密度)(p=0.060)的比例低于无 DM 患者。

结论

多支血管 CAD 疾病患者的 LDL3 亚组分和 IDL-C 水平较高,IDLA 比例较低。

相似文献

1
Cholesterol Subfraction Analysis in Patients with Acute Coronary Syndrome.急性冠状动脉综合征患者的胆固醇亚组份分析。
Curr Vasc Pharmacol. 2019;17(4):365-375. doi: 10.2174/1570161116666180601083225.
2
The Pt-Cr everolimus-eluting stent with bioabsorbable polymer in the treatment of patients with acute coronary syndromes. Results from the SYNERGY ACS registry.采用含生物可吸收聚合物的铂铬依维莫司洗脱支架治疗急性冠状动脉综合征患者。SYNERGY ACS注册研究结果。
Cardiovasc Revasc Med. 2019 Aug;20(8):705-710. doi: 10.1016/j.carrev.2018.10.019. Epub 2018 Oct 18.
3
Outcomes in patients with acute coronary syndrome in a referral hospital in sub-Saharan Africa.撒哈拉以南非洲一家转诊医院急性冠状动脉综合征患者的治疗结果。
Cardiovasc J Afr. 2019;30(1):29-33. doi: 10.5830/CVJA-2018-066. Epub 2018 Dec 4.
4
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes.当代欧洲注册研究中急性冠脉综合征合并糖尿病患者的特征与结局。
Eur Heart J Cardiovasc Pharmacother. 2017 Oct 1;3(4):198-213. doi: 10.1093/ehjcvp/pvw049.
5
Sustained risk of stent thrombosis and restenosis in first generation drug-eluting Stents after One Decade of Follow-up: A Report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).第一代药物洗脱支架十年随访后支架血栓形成和再狭窄的持续风险:来自瑞典冠状动脉血管造影和血管成形术登记处(SCAAR)的报告。
Catheter Cardiovasc Interv. 2018 Nov 15;92(6):E403-E409. doi: 10.1002/ccd.27655. Epub 2018 May 10.
6
Incidence, Clinical Characteristics, and Impact of Acute Coronary Syndrome Following Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后急性冠状动脉综合征的发生率、临床特征及影响。
JACC Cardiovasc Interv. 2018 Dec 24;11(24):2523-2533. doi: 10.1016/j.jcin.2018.09.001.
7
Impact of an optical coherence tomography guided approach in acute coronary syndromes: A propensity matched analysis from the international FORMIDABLE-CARDIOGROUP IV and USZ registry.光学相干断层扫描引导方法在急性冠状动脉综合征中的影响:来自国际FORMIDABLE-CARDIOGROUP IV和苏黎世大学医院登记处的倾向匹配分析。
Catheter Cardiovasc Interv. 2017 Aug 1;90(2):E46-E52. doi: 10.1002/ccd.26880. Epub 2016 Dec 28.
8
Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study.与低密度脂蛋白胆固醇相比,非高密度脂蛋白胆固醇是否是急性心肌梗死后患者长期预后的更好预测指标?一项回顾性研究。
BMC Cardiovasc Disord. 2017 Jan 5;17(1):10. doi: 10.1186/s12872-016-0450-9.
9
Elevated plasma levels of Mac-2 binding protein predict poor cardiovascular outcomes in patients with acute coronary syndrome.血浆中Mac-2结合蛋白水平升高预示急性冠脉综合征患者心血管预后不良。
Coron Artery Dis. 2017 Dec;28(8):683-689. doi: 10.1097/MCA.0000000000000540.
10
Relation of Low-Density Lipoprotein Cholesterol With Microvascular Injury and Clinical Outcome in Revascularized ST-Elevation Myocardial Infarction.在经再血管化治疗的 ST 段抬高型心肌梗死患者中,低密度脂蛋白胆固醇与微血管损伤及临床结局的关系。
J Am Heart Assoc. 2017 Oct 10;6(10):e006957. doi: 10.1161/JAHA.117.006957.

引用本文的文献

1
2024 Guidelines of the Polish Society of Laboratory Diagnostics and the Polish Lipid Association on laboratory diagnostics of lipid metabolism disorders.波兰实验室诊断学会和波兰脂质协会2024年脂质代谢紊乱实验室诊断指南。
Arch Med Sci. 2024 Mar 18;20(2):357-374. doi: 10.5114/aoms/186191. eCollection 2024.
2
A Complex Heterogeneous Network Model of Disease Regulated by Noncoding RNAs: A Case Study of Unstable Angina Pectoris.非编码 RNA 调控疾病的复杂异质网络模型:以不稳定型心绞痛为例。
Comput Intell Neurosci. 2022 Dec 23;2022:5852089. doi: 10.1155/2022/5852089. eCollection 2022.
3
Relationship between subclasses low-density lipoprotein and carotid plaque.低密度脂蛋白亚类与颈动脉斑块之间的关系。
Transl Neurosci. 2022 Mar 3;13(1):30-37. doi: 10.1515/tnsci-2022-0210. eCollection 2022 Jan 1.
4
Associations between the lipid profile and the development of hypertension in young individuals - the preliminary study.年轻个体血脂谱与高血压发生之间的关联——初步研究
Arch Med Sci. 2019 Jun 27;18(1):25-35. doi: 10.5114/aoms.2019.86197. eCollection 2022.
5
High-Density Lipoprotein Subfractions: Much Ado about Nothing or Clinically Important?高密度脂蛋白亚组分:无事生非还是具有临床重要性?
Biomedicines. 2021 Jul 18;9(7):836. doi: 10.3390/biomedicines9070836.
6
Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?高密度脂蛋白亚群:慢性肾脏病心血管疾病风险中的友或敌?
Biomedicines. 2021 May 16;9(5):554. doi: 10.3390/biomedicines9050554.
7
2020 Guidelines of the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA) on laboratory diagnostics of lipid metabolism disorders.波兰实验室诊断学会(PSLD)和波兰脂质协会(PoLA)2020年脂质代谢紊乱实验室诊断指南。
Arch Med Sci. 2020 Mar 2;16(2):237-252. doi: 10.5114/aoms.2020.93253. eCollection 2020.
8
Lipid transfer to high-density lipoproteins in coronary artery disease patients with and without previous cerebrovascular ischemic events.在有和无先前脑血管缺血事件的冠心病患者中,脂质向高密度脂蛋白的转移。
Clin Cardiol. 2019 Nov;42(11):1100-1105. doi: 10.1002/clc.23259. Epub 2019 Sep 6.